Abeona sells speedy drug review voucher for $155M
Bio Pharma Dive
MAY 12, 2025
The biotech has quickly turned a cell therapy approval into one of the more lucrative recent sales for a priority review voucher, which companies can use to fast track drug reviews.
Let's personalize your content